Vilon is a synthetic peptide composed of the amino acids lysine and glutamic acid, classified as a bioactive compound with potential therapeutic applications. Researchers primarily study Vilon for its effects on cancer modulation, aging, and metabolic functions. Key findings from various studies indicate that Vilon can enhance survival rates in mice with transplanted tumors, stimulate gene expression in cardiac tissue, and improve intestinal enzyme activity in aged rats. Additionally, preclinical evidence suggests that Vilon may exert beneficial effects on homeostasis during chronic renal failure by reducing specific inflammatory markers. Current research continues to explore its multifaceted roles in health and disease, highlighting its potential as a geroprotective agent and its interactions with other therapeutic compounds.